<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01017887</url>
  </required_header>
  <id_info>
    <org_study_id>IRB09-107</org_study_id>
    <nct_id>NCT01017887</nct_id>
  </id_info>
  <brief_title>Intraperitoneal Carbon Dioxide Concentration Measurement During Standard Laparoscopy With a New Airseal Access Port</brief_title>
  <official_title>SurgiQuest AirSeal CO2 Gas Quality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baystate Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baystate Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The new AirSeal access port for laparoscopic surgery does not use a mechanical valve on the&#xD;
      port to maintain gas in the peritoneal cavity. It uses an invisible barrier created by high&#xD;
      flow gas jets within the port. The percentage of carbon dioxide, the standard gas used for&#xD;
      laparoscopy, during laparoscopic surgery has not been previously measured, but is probably&#xD;
      high. The investigators aim to measure the percentage of intraperitoneal carbon dioxide with&#xD;
      standard ports and the AirSeal port during a variety of conditions during laparoscopic&#xD;
      procedures including suturing and suctioning. The study period will commence at the start of&#xD;
      the operation, and be completed upon discharge from the hospital or postoperative day 5,&#xD;
      whichever is shorter. All devices are approved for use in humans by the FDA, and are being&#xD;
      used for their intended purpose.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The SurgiQuest AirSeal system is approved by the Food and Drug Administration (FDA) as access&#xD;
      port for laparoscopic surgery that utilizes an invisible air curtain rather than a mechanical&#xD;
      barrier to maintain pneumoperitoneum. In addition to the cannula, there is special filtration&#xD;
      tubing and an air pump that act in concert with an existing CO2 insufflator. The system has&#xD;
      been approved for use and purchase at Baystate Medical Center by the value analysis&#xD;
      committee. Despite FDA approval and extensive laboratory testing, there is still no human&#xD;
      data regarding intraperitoneal CO2 levels under a variety of conditions one would normally&#xD;
      experience during a laparoscopic operation. The specific aim of this study is to measure&#xD;
      these levels during laparoscopic cases in humans. We hypothesize that there will be no more&#xD;
      than minimal alteration of intraperitoneal CO2 levels when using the AirSeal system when&#xD;
      compared to the standard laparoscopic system. The follow-up to this is examining evidence of&#xD;
      extraperitoneal gas extravasation. This will occur as part of routine post-operative care,&#xD;
      but we will be collecting data, that will be de-identified in the post-operative period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Unable to recruit any subjects&#xD;
  </why_stopped>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>percent of intraperitoneal carbon dioxide during surgery</measure>
    <time_frame>intraoperative - starts at beginning of the operation and ends at the completion of the operation</time_frame>
    <description>intraperitoneal carbon dioxide measurements intraoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>subcutaneous emphysema</measure>
    <time_frame>during the patients hospital stay, or the first 5 days postoperatively.</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Laparoscopic Carbon Dioxide Measurement</condition>
  <arm_group>
    <arm_group_label>Airseal port for laparoscopic surgery</arm_group_label>
    <description>Airseal access port for laparoscopic surgery with standard ports.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Laparoscopy ports</arm_group_label>
    <description>Uses standard laparoscopy ports.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Airseal access port for laparoscopic surgery</intervention_name>
    <description>The investigators will utilize this access port that is already approved by the FDA for it's intended use in laparoscopic surgery. The investigators are simply measuring the percentage of carbon dioxide in the peritoneal cavity.</description>
    <arm_group_label>Airseal port for laparoscopic surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Laparoscopy ports</intervention_name>
    <description>Prospective monitoring of CO2 levels during laparoscopic surgery with standard access ports.</description>
    <arm_group_label>Airseal port for laparoscopic surgery</arm_group_label>
    <arm_group_label>Standard Laparoscopy ports</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergoing a laparoscopic operation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all patients undergoing a laparoscopic operation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Earle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baystate Medical Center</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>September 2013</verification_date>
  <study_first_submitted>August 4, 2009</study_first_submitted>
  <study_first_submitted_qc>November 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2009</study_first_posted>
  <last_update_submitted>September 3, 2013</last_update_submitted>
  <last_update_submitted_qc>September 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baystate Medical Center</investigator_affiliation>
    <investigator_full_name>David Earle</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>laparoscopy</keyword>
  <keyword>airseal</keyword>
  <keyword>carbon dioxide</keyword>
  <keyword>insufflation</keyword>
  <keyword>pneumoperitoneum</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

